肝细胞癌术后复发风险因素及预测模型分析
Analysis of Risk Factors and Prediction Models for Postoperative Recurrence of Hepatocellular Carcinoma
DOI: 10.12677/acm.2025.15113261, PDF,    科研立项经费支持
作者: 秦 蕊, 李 欢, 王龙胜*:安徽医科大学第二附属医院放射科,安徽 合肥
关键词: 肝细胞癌术后复发风险因素Logistic回归预测模型Hepatocellular Carcinoma Postoperative Recurrence Risk Factors Logistic Regression Predictive Model
摘要: 目的:探讨肝细胞癌(HCC)患者术后复发的临床及影像学风险因素,并构建预测模型。方法:回顾性分析143例经病理确诊并接受根治性切除的HCC患者,根据术后3个月CT复查结果分为复发组(84例)和未复发组(59例)。通过组间差异分析及Logistic回归筛选术后复发的独立风险因素,并构建多因素预测模型,采用ROC曲线评估模型效能。结果:微血管浸润、病灶数目及浸润程度为HCC术后复发的独立预测因素(P < 0.05)。ROC分析显示,去除病灶数目的对比模型相比全因素模型,AUC值具有最大的下降,由0.796下降至0.765,表明病灶数目在预测HCC术后复发中具有重要贡献。结论:微血管浸润、病灶数目及浸润程度是HCC术后复发的关键独立预测因素,其中病灶数目与浸润程度对模型预测效能的提升作用更为显著。基于三项独立变量建立的多因素模型可较准确地预测HCC术后复发风险,为术后个体化管理提供重要参考。
Abstract: Objective: To investigate the clinical and imaging risk factors for postoperative recurrence in patients with hepatocellular carcinoma (HCC) and to construct a predictive model. Methods: A retrospective analysis was conducted on 143 patients with pathologically confirmed HCC who underwent curative resection. Based on CT re-examination at 3 months post-surgery, patients were classified into a recurrence group (n = 84) and a non-recurrence group (n = 59). Intergroup comparisons and logistic regression analyses were performed to identify independent risk factors for postoperative recurrence, and a multivariate predictive model was established. The model’s performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results: Microvascular invasion, number of lesions, and degree of invasion were identified as independent predictors of postoperative recurrence (P < 0.05). ROC analysis showed that among the comparison models, the model excluding the number of lesions exhibited the largest decrease in AUC, declining from 0.796 in the full-factor model to 0.765, indicating that the number of lesions makes an important contribution to predicting postoperative recurrence in HCC. Conclusion: Microvascular invasion, number of lesions, and degree of invasion are key independent predictors of postoperative recurrence in HCC, with the number of lesions and degree of invasion contributing most significantly to the predictive performance of the model. A multivariate model based on these three factors can accurately predict postoperative recurrence risk and provide valuable guidance for individualized postoperative management.
文章引用:秦蕊, 李欢, 王龙胜. 肝细胞癌术后复发风险因素及预测模型分析[J]. 临床医学进展, 2025, 15(11): 1599-1608. https://doi.org/10.12677/acm.2025.15113261

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Balogh, J., Victor, D., Asham, E.H., Burroughs, S.G., Boktour, M., Saharia, A., et al. (2016) Hepatocellular carcinoma: A Review. Journal of Hepatocellular Carcinoma, 3, 41-53. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, Z., Jiang, C., Qiang, Z., Zhou, Y., Ji, J., Zeng, Y., et al. (2024) Role of Microvascular Invasion in Early Recurrence of Hepatocellular Carcinoma after Liver Resection: A Literature Review. Asian Journal of Surgery, 47, 2138-2143. [Google Scholar] [CrossRef] [PubMed]
[4] Herrero, A., Toubert, C., Bedoya, J.U., Assenat, E., Guiu, B., Panaro, F., et al. (2024) Management of Hepatocellular Carcinoma Recurrence after Liver Surgery and Thermal Ablations: State of the Art and Future Perspectives. Hepatobiliary Surgery and Nutrition, 13, 71-88. [Google Scholar] [CrossRef] [PubMed]
[5] Schraiber, L.D.S., de Mattos, A.A., Zanotelli, M.L., Cantisani, G.P.C., Brandão, A.B.d.M., Marroni, C.A., et al. (2016) Alpha-Fetoprotein Level Predicts Recurrence after Transplantation in Hepatocellular Carcinoma. Medicine, 95, e2478. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, M., Li, C., Liang, L., Xing, H., Sun, L., Quan, B., et al. (2020) Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma. The Oncologist, 25, e1541-e1551. [Google Scholar] [CrossRef] [PubMed]
[7] Xu, X., Xing, H., Han, J., Li, Z., Lau, W., Zhou, Y., et al. (2019) Risk Factors, Patterns, and Outcomes of Late Recurrence after Liver Resection for Hepatocellular Carcinoma: A Multicenter Study from China. JAMA Surgery, 154, 209-217. [Google Scholar] [CrossRef] [PubMed]
[8] Kocheise, L., Schoenlein, M., Behrends, B., Joerg, V., Casar, C., Fruendt, T.W., et al. (2023) EpCAM-Positive Circulating Tumor Cells and Serum AFP Levels Predict Outcome after Curative Resection of Hepatocellular Carcinoma. Scientific Reports, 13, Article No. 20827. [Google Scholar] [CrossRef] [PubMed]
[9] Xu, Z., Yuan, W., Zhou, Y. and Yue, T. (2024) Development and Nomogram Prediction of Early Postoperative Recurrence in Hepatocellular Carcinoma Based on Preoperative CT Imaging Radiomic Features and Serum Features Related to Microvascular Infiltration. Journal of Gastrointestinal Oncology, 15, 2630-2641. [Google Scholar] [CrossRef] [PubMed]
[10] Yan, W., Li, C., Yao, L., Qiu, H., Wang, M., Xu, X., et al. (2021) Predictors and Long-Term Prognosis of Early and Late Recurrence for Patients Undergoing Hepatic Resection of Hepatocellular Carcinoma: A Large-Scale Multicenter Study. Hepatobiliary Surgery and Nutrition, 12, 155-168. [Google Scholar] [CrossRef] [PubMed]
[11] Hong, S.B., Choi, S.H., Kim, S.Y., Shim, J.H., Lee, S.S., Byun, J.H., et al. (2021) MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Liver Cancer, 10, 94-106. [Google Scholar] [CrossRef] [PubMed]
[12] Sheng, X., Ji, Y., Ren, G., Lu, C., Yun, J., Chen, L., et al. (2020) A Standardized Pathological Proposal for Evaluating Microvascular Invasion of Hepatocellular Carcinoma: A Multicenter Study by LCPGC. Hepatology International, 14, 1034-1047. [Google Scholar] [CrossRef] [PubMed]
[13] Li, Q., Wei, Y., Zhang, T., Che, F., Yao, S., Wang, C., et al. (2023) Predictive Models and Early Postoperative Recurrence Evaluation for Hepatocellular Carcinoma Based on Gadoxetic Acid-Enhanced MR Imaging. Insights into Imaging, 14, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[14] Ikeda, K., Saitoh, S., Tsubota, A., Arase, Y., Chayama, K., Kumada, H., et al. (1993) Risk Factors for Tumor Recurrence and Prognosis after Curative Resection of Hepatocellular Carcinoma. Cancer, 71, 19-25. [Google Scholar] [CrossRef] [PubMed]
[15] Shah, S.A., Cleary, S.P., Wei, A.C., Yang, I., Taylor, B.R., Hemming, A.W., et al. (2007) Recurrence after Liver Resection for Hepatocellular Carcinoma: Risk Factors, Treatment, and Outcomes. Surgery, 141, 330-339. [Google Scholar] [CrossRef] [PubMed]
[16] Xu, X., Diao, Y., Zeng, Y., Li, C., Li, F., Sun, L., et al. (2023) Association of Severity in the Grading of Microvascular Invasion with Long-Term Oncological Prognosis after Liver Resection for Early-Stage Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study from a Hepatitis B Virus-Endemic Area. International Journal of Surgery, 109, 841-849. [Google Scholar] [CrossRef] [PubMed]
[17] Poon, R.T.-P., Fan, S. and Wong, J. (2000) Risk Factors, Prevention, and Management of Postoperative Recurrence after Resection of Hepatocellular Carcinoma. Annals of Surgery, 232, 10-24. [Google Scholar] [CrossRef] [PubMed]
[18] Banerjee, S., Wang, D.S., Kim, H.J., Sirlin, C.B., Chan, M.G., Korn, R.L., et al. (2015) A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma. Hepatology, 62, 792-800. [Google Scholar] [CrossRef] [PubMed]
[19] Rodríguez-Perálvarez, M., Luong, T.V., Andreana, L., Meyer, T., Dhillon, A.P. and Burroughs, A.K. (2013) A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability. Annals of Surgical Oncology, 20, 325-339. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, M., Ji, Y., Zeng, Z., Tang, Z., Fan, J., Zhou, J., et al. (2010) Impact Factors for Microinvasion in Patients with Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume. International Journal of Radiation Oncology Biology Physics, 76, 467-476. [Google Scholar] [CrossRef] [PubMed]
[21] Si, M., Amersi, F., Golish, S.R., Ortiz, J.A., Zaky, J., Finklestein, D., et al. (2003) Prevalence of Metastases in Hepatocellular Carcinoma: Risk Factors and Impact on Survival. The American Surgeon, 69, 879-885. [Google Scholar] [CrossRef
[22] Rhee, H., An, C., Kim, H., Yoo, J.E., Park, Y.N. and Kim, M. (2019) Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features. Liver Cancer, 8, 24-40. [Google Scholar] [CrossRef] [PubMed]
[23] Nevola, R., Ruocco, R., Criscuolo, L., Villani, A., Alfano, M., Beccia, D., et al. (2023) Predictors of Early and Late Hepatocellular Carcinoma Recurrence. World Journal of Gastroenterology, 29, 1243-1260. [Google Scholar] [CrossRef] [PubMed]
[24] Alves, R., Gomes, M.T., Macedo, C.S., Miranda, H.P. and Nery, F. (2015) Hepatocellular Carcinoma Treatment Strategies—A Case-Based Review. Journal of Solid Tumors, 5, 120-136. [Google Scholar] [CrossRef
[25] Yang, L., Gu, D., Wei, J., Yang, C., Rao, S., Wang, W., et al. (2019) A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer, 8, 373-386. [Google Scholar] [CrossRef] [PubMed]
[26] Xie, D., Fan, H., Ren, Z., Fan, J. and Gao, Q. (2019) Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications. Clinical and Translational Gastroenterology, 10, e00006. [Google Scholar] [CrossRef] [PubMed]